Tenofovir therapy is associated with increased urinary phosphate excretion and decreased bone mineral density in patients with chronic hepatitis B

被引：0
|
作者：
Le, S. [1 ,2 ]
Wong, P. [3 ,4 ,5 ]
Shochet, I. [6 ]
Doyle, A. [1 ]
Shelton, E. [1 ]
Milat, F. [3 ,4 ,5 ]
Sievert, W. [1 ,2 ]
机构：
[1] Monash Hlth, Dept Gastroenterol & Hepatol, Clayton, Vic 3168, Australia
[2] Monash Univ, Ctr Inflammatory Dis, Clayton, Vic 3168, Australia
[3] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
[4] Monash Hlth, Dept Endocrinol, Clayton, Vic 3168, Australia
[5] Monash Univ, Dept Med, Southern Clin Sch, Clayton, Vic 3168, Australia
[6] Monash Hlth, Dept Gen Med, Clayton, Vic 3168, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [11] Prospective Assessment Of Frequency And Factors Associated With Bone Loss During Tenofovir Therapy In Patients With Chronic Hepatitis B
    Alawad, Ahmad S.
    Suarez, Daniel F.
    Auh, Sungyoung
    Rivera, Elenita
    Ghany, Marc G.
    HEPATOLOGY, 2017, 66 : 1025A - 1025A
  • [12] Smaller decreases in bone mineral density in chronic hepatitis B patients receiving tenofovir alafenamide compared with tenofovir disoproxil fumarate over 96 weeks
    Fung, S.
    Chuang, W. L.
    Nishiguchi, S.
    Seto, W. K.
    Tak, W. Y.
    Erne, E. M.
    Jablkowski, M.
    Morozov, V.
    Lau, A. H.
    Suri, V.
    Flaherty, J. F.
    Kim, K.
    Gaggar, A.
    Subramanian, G. M.
    Celen, M.
    Lim, S-G
    Chan, H. L.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S691 - S692
  • [13] Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B
    Tseng, Tzu-Ning
    Chen, Chien-Hung
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (05) : 916 - 917
  • [14] FRAX score in the assessment of Bone Mineral Density changes in Tenofovir treated Chronic Hepatitis B patients: comparison with bone biochemistry and DEXA scanning
    Gill, Upkar
    Zissimopoulos, Alexandra
    Al-Shamma, Safa
    Burke, Katherine B.
    Ross, Valerie A.
    Kallis, Yiannis
    Kooner, Paul
    Marley, Richard
    Foster, Graham R.
    Kennedy, Patrick T.
    HEPATOLOGY, 2012, 56 : 201A - 201A
  • [15] Increased bone mineral density in patients with chronic hypoparathyroidism
    Chan, FKW
    Tiu, SC
    Choi, KL
    Choi, CH
    Kong, APS
    Shek, CC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07): : 3155 - 3159
  • [16] Improvement of bone mineral density and markers of proximal renal tubular function in chronic hepatitis B patients switched from tenofovir disoproxil fumarate to tenofovir alafenamide
    Fong, Tse-Ling
    Lee, Brian T.
    Tien, Andy
    Chang, Mimi
    Lim, Carolina
    Ahn, Alden
    Bae, Ho S.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (05) : 561 - 567
  • [17] Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis C
    Solís-Herruzo, JA
    Castellano, G
    Fernández, I
    Muñoz, R
    Hawkins, F
    JOURNAL OF HEPATOLOGY, 2000, 33 (05) : 812 - 817
  • [18] Comparison of renal safety and bone mineral density of tenofovir and entecavir in patients with chronic hepatitis B: a systematic review and meta-analysis
    Yang, Xiaoxian
    Yan, Haiyi
    Zhang, Xiuju
    Qin, Xueying
    Guo, Peng
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 124 : 133 - 142
  • [19] Increased RANKL expression in peripheral T cells is associated with decreased bone mineral density in patients with COPD
    Chen, Ying
    Bai, Peng
    Liu, Lili
    Han, Junyan
    Zeng, Hui
    Sun, Yongchang
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 (02) : 585 - 593
  • [20] Bone mineral density during interferon therapy for chronic hepatitis C
    Menozzi, G
    Villa, A
    Redaelli, A
    Libera, E
    Pozzi, M
    Pioltelli, P
    Roffi, L
    JOURNAL OF HEPATOLOGY, 2001, 34 : 172 - 172
12345